Analysis Version
v1
History
Back to Study: HMG-coenzyme A reductase inhibition, type 2 diabet...
causal
Analysis v1
59
Pro
0
Against

Even though statins make you gain a little weight, that tiny gain can’t explain why you’re 11% more likely to get diabetes — something else about blocking HMGCR is making your body worse at handling sugar.

Evidence Quality Assessment

Claim Status

appropriately stated

Study Design Support

Design supports claim

Appropriate Language Strength

definitive

Can make definitive causal claims

Assessment Explanation

The meta-regression analysis of trial data shows no association between weight change and diabetes risk (p=0.29), and the effect sizes are quantitatively inconsistent. This supports a definitive conclusion that weight gain is not the primary driver.

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.

Evidence from Studies

Supporting (1)

59
59

HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials

Systematic Review With Meta-Analysis
Human

The study found that while statins cause a tiny bit of weight gain, that alone can’t explain why people on statins get diabetes more often — something else about how statins affect the body must be causing the extra risk.

Contradicting (0)

0
No contradicting evidence found

Source Study

HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials

Score: 59
DOI: 10.1016/S0140-6736(14)61183-1

Similar Assertions

Even high-dose statins don’t make you gain more weight than low-dose ones — but they still raise your diabetes risk more — meaning weight gain isn’t the reason higher doses are riskier.

59
0
91%

HMG-CoA reductase inhibition with statins modestly increases the risk of developing type 2 diabetes, particularly in individuals with pre-existing insulin resistance.

64
47
87%

Blocking the HMGCR enzyme — whether by statin drugs or your genes — makes you about 11–12% more likely to develop type 2 diabetes, and this isn’t because the drugs lower cholesterol.

59
0
81%

Taking statins or having a specific gene version makes people gain a little bit of weight and get a slightly bigger waist, even if they don’t eat more — this is because blocking the HMGCR enzyme affects how the body stores fat.

59
0
79%

People with a gene version that blocks HMGCR have slightly higher blood sugar and insulin levels — meaning their bodies are less efficient at managing sugar, even before they become diabetic.

59
0
77%